296 related articles for article (PubMed ID: 19481003)
1. Latent infection and tuberculosis disease in rheumatoid arthritis patients.
Acevedo-Vásquez E; Ponce de León D; Gamboa-Cárdenas R
Rheum Dis Clin North Am; 2009 Feb; 35(1):163-81. PubMed ID: 19481003
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications of biologic agents.
Martin-Mola E; Balsa A
Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
[TBL] [Abstract][Full Text] [Related]
3. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis in the age of biologic therapy.
Hernandez C; Cetner AS; Jordan JE; Puangsuvan SN; Robinson JK
J Am Acad Dermatol; 2008 Sep; 59(3):363-80; quiz 382-4. PubMed ID: 18694676
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha--California, 2002-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(30):683-6. PubMed ID: 15295313
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostics of latent tuberculosis (TB) in adult vaccinated patients (BCG) in Croatia before introduction of tumor necrosis factor antagonist therapy].
Popović-Grle S; Babić-Naglić D
Reumatizam; 2008; 55(1):31-5. PubMed ID: 19024268
[TBL] [Abstract][Full Text] [Related]
7. Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade.
Wallis RS
Arthritis Rheum; 2008 Apr; 58(4):947-52. PubMed ID: 18383389
[TBL] [Abstract][Full Text] [Related]
8. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.
Bieber J; Kavanaugh A
Rheum Dis Clin North Am; 2004 May; 30(2):257-70, v. PubMed ID: 15172039
[TBL] [Abstract][Full Text] [Related]
9. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies.
Keane J; Bresnihan B
Curr Opin Rheumatol; 2008 Jul; 20(4):443-9. PubMed ID: 18525359
[TBL] [Abstract][Full Text] [Related]
11. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
Theis VS; Rhodes JM
Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
[TBL] [Abstract][Full Text] [Related]
12. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
[TBL] [Abstract][Full Text] [Related]
14. How to manage infections in the era of biologics?
Saraceno R; Chimenti S
Dermatol Ther; 2008; 21(3):180-6. PubMed ID: 18564248
[TBL] [Abstract][Full Text] [Related]
15. Conversion to positive tuberculosis test during etanercept treatment of psoriasis.
Sumner W; Feldman SR
J Drugs Dermatol; 2007 Oct; 6(10):1048. PubMed ID: 17966185
[TBL] [Abstract][Full Text] [Related]
16. Novel screening tools for latent tuberculosis: time to leave an old friend?
Villiger PM; Zellweger JP; Möller B
Curr Opin Rheumatol; 2009 May; 21(3):238-43. PubMed ID: 19346950
[TBL] [Abstract][Full Text] [Related]
17. Association of infections and tuberculosis with antitumor necrosis factor alpha therapy.
Patkar NM; Teng GG; Curtis JR; Saag KG
Curr Opin Rheumatol; 2008 May; 20(3):320-6. PubMed ID: 18388525
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis screening before biologics -- T-SPOT for all?
Gilham L; France J; Stirling A; Bawa S
J Rheumatol; 2011 Jan; 38(1):179. PubMed ID: 21196587
[No Abstract] [Full Text] [Related]
19. Correlation between the response to Mycobacterium tuberculosis antigens and the tuberculin skin test in patients with rheumatoid arthritis in Colombia.
López Y; Vargas F; Velásquez M; Ortiz C; Rodríguez LM; París S; García LF; Baena A; Vásquez G
Biomedica; 2013; 33(2):226-32. PubMed ID: 24652132
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-α treatment: every new solution breeds new doubts.
Sánchez-Moya AI; Daudén E
Br J Dermatol; 2011 Jan; 164(1):208-9. PubMed ID: 21054332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
